Pancreatic cancer
Pancreatic cancer occurs in tissues of the pancreas. The pancreatic organ plays a vital role in digestion by producing digestive enzymes to help break down foods. Pancrease also produces hormones, including insulin, that help manage blood sugar levels. Pancreatic cancer is known for its aggressive nature. It is also difficult to diagnose in its early stages because symptoms often do not appear until the cancer is advanced. Symptoms and signs of pancreatic cancer include abdominal pain, weight loss, jaundice, and loss of appetite. The exact etiology of pancreatic cancer is still largely unknown, but risk factors include smoking, chronic pancreatitis, diabetes, and certain hereditary conditions. Treatment for pancreatic cancer include various modalities like surgery, chemotherapy, and radiation therapy. Despite advances in treatment, this cancer has one of the lowest survival rate, highlighting the importance of early detection and need for development of more effective treatment strategies.
Pancreatic cancer
Latest Posts
-
Vitamin B6 in Pancreatic Cancer: A Challenge and Opportunity
Research from the University of Oklahoma College of Medicine reveals how pancreatic ductal adenocarcinoma (PDAC) cells exploit vitamin B6 to enhance their growth and weaken natural killer (NK) cells, compromising the immune response. An innovative strategy involving…
-
Calcium channel blockers used for hypertension has potential to block cancer invasion
By screening already approved drugs, the team led by Postdoctoral Researcher Guillaume Jacquemet and Academy Professor Johanna Ivaska has discovered that calcium channel blockers can efficiently stop cancer cell invasion in vitro. Calcium channel blockers are currently…
-
Synthetic binding protein called "NS1 Monobody" found to inhibit common cancer causing (RAS) mutation
Monobody NS1 binds to H-RAS or K-RAS protein and blocksRAS function by disrupting the protein’s ability to form active molecular pairs. Credit: John P. O’Bryan, et al. Researchers at the University of Illinois at Chicago have identified a new…
-
Synthetic binding protein called “NS1 Monobody” found to inhibit common cancer causing (RAS) mutation
Monobody NS1 binds to H-RAS or K-RAS protein and blocksRAS function by disrupting the protein’s ability to form active molecular pairs. Credit: John P. O’Bryan, et al. Researchers at the University of Illinois at Chicago have identified a new…
-
Research links collagen structural changes to worse prognosis in pancreatic cancer
(Madison) University of Wisconsin-Madison researchers found first evidence linking a disturbance of the most common protein in the body with a poor outcome in pancreatic cancer. Results of the study are published in the journal Oncotarget. The study…
-
Scientists Identify Potential Pancreatic Cancer Target SLC6A14
Researchers have found that a protein called SLC6A14 is overexpressed by several fold in pancreatic tumors taken from patients and in cancerous pancreatic cells lines compared with normal pancreatic tissue or normal pancreatic cells. SLC6A14 transports amino…
You must be logged in to post a comment.